A citation-based method for searching scientific literature

Phillip L Molyneaux, Michael J Cox, Saffron A G Willis-Owen, Patrick Mallia, Kirsty E Russell, Anne-Marie Russell, Elissa Murphy, Sebastian L Johnston, David A Schwartz, Athol U Wells, William O C Cookson, Toby M Maher, Miriam F Moffatt. Am J Respir Crit Care Med 2014
Times Cited: 266







List of co-cited articles
959 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.
MeiLan K Han, Yueren Zhou, Susan Murray, Nabihah Tayob, Imre Noth, Vibha N Lama, Bethany B Moore, Eric S White, Kevin R Flaherty, Gary B Huffnagle,[...]. Lancet Respir Med 2014
206
54

Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
David N O'Dwyer, Shanna L Ashley, Stephen J Gurczynski, Meng Xia, Carol Wilke, Nicole R Falkowski, Katy C Norman, Kelly B Arnold, Gary B Huffnagle, Margaret L Salisbury,[...]. Am J Respir Crit Care Med 2019
68
54

Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.
Philip L Molyneaux, Saffron A G Willis-Owen, Michael J Cox, Phillip James, Steven Cowman, Michael Loebinger, Andrew Blanchard, Lindsay M Edwards, Carmel Stock, Cécile Daccord,[...]. Am J Respir Crit Care Med 2017
89
34

Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.
Philip L Molyneaux, Michael J Cox, Athol U Wells, Ho Cheol Kim, Wonjun Ji, William O C Cookson, Miriam F Moffatt, Dong Soon Kim, Toby M Maher. Respir Res 2017
79
35

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
824
23

Disordered microbial communities in asthmatic airways.
Markus Hilty, Conor Burke, Helder Pedro, Paul Cardenas, Andy Bush, Cara Bossley, Jane Davies, Aaron Ervine, Len Poulter, Lior Pachter,[...]. PLoS One 2010
915
23

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
21

Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis.
Yong Huang, Shwu-Fan Ma, Milena S Espindola, Rekha Vij, Justin M Oldham, Gary B Huffnagle, John R Erb-Downward, Kevin R Flaherty, Beth B Moore, Eric S White,[...]. Am J Respir Crit Care Med 2017
71
29

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
996
20

A common MUC5B promoter polymorphism and pulmonary fibrosis.
Max A Seibold, Anastasia L Wise, Marcy C Speer, Mark P Steele, Kevin K Brown, James E Loyd, Tasha E Fingerlin, Weiming Zhang, Gunnar Gudmundsson, Steve D Groshong,[...]. N Engl J Med 2011
587
20

The Microbiome and the Respiratory Tract.
Robert P Dickson, John R Erb-Downward, Fernando J Martinez, Gary B Huffnagle. Annu Rev Physiol 2016
284
19

Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent.
Rachele Invernizzi, Joseph Barnett, Bhavin Rawal, Arjun Nair, Poonam Ghai, Shaun Kingston, Felix Chua, Zhe Wu, Athol U Wells, Elizabeth R Renzoni,[...]. Eur Respir J 2020
23
82

Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial.
Ludmila Shulgina, Anthony P Cahn, Edwin R Chilvers, Helen Parfrey, Allan B Clark, Edward C F Wilson, Orion P Twentyman, Anthony G Davison, John J Curtin, Michael B Crawford,[...]. Thorax 2013
107
18

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
17

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
17

Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Imre Noth, Yingze Zhang, Shwu-Fan Ma, Carlos Flores, Mathew Barber, Yong Huang, Steven M Broderick, Michael S Wade, Pirro Hysi, Joseph Scuirba,[...]. Lancet Respir Med 2013
296
17

Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype.
Leopoldo N Segal, Jose C Clemente, Jun-Chieh J Tsay, Sergei B Koralov, Brian C Keller, Benjamin G Wu, Yonghua Li, Nan Shen, Elodie Ghedin, Alison Morris,[...]. Nat Microbiol 2016
198
15

Bacterial Topography of the Healthy Human Lower Respiratory Tract.
Robert P Dickson, John R Erb-Downward, Christine M Freeman, Lisa McCloskey, Nicole R Falkowski, Gary B Huffnagle, Jeffrey L Curtis. mBio 2017
166
15

Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin.
Sarah Knippenberg, Bianca Ueberberg, Regina Maus, Jennifer Bohling, Nadine Ding, Meritxell Tort Tarres, Heinz-Gerd Hoymann, Danny Jonigk, Nicole Izykowski, James C Paton,[...]. Thorax 2015
47
31

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
382
14

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
Harold R Collard, Christopher J Ryerson, Tamera J Corte, Gisli Jenkins, Yasuhiro Kondoh, David J Lederer, Joyce S Lee, Toby M Maher, Athol U Wells, Katerina M Antoniou,[...]. Am J Respir Crit Care Med 2016
489
13

Muc5b is required for airway defence.
Michelle G Roy, Alessandra Livraghi-Butrico, Ashley A Fletcher, Melissa M McElwee, Scott E Evans, Ryan M Boerner, Samantha N Alexander, Lindsey K Bellinghausen, Alfred S Song, Youlia M Petrova,[...]. Nature 2014
377
13

Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis.
Youhei Takahashi, Atsushi Saito, Hirofumi Chiba, Koji Kuronuma, Kimiyuki Ikeda, Tomofumi Kobayashi, Shigeru Ariki, Motoko Takahashi, Yasushi Sasaki, Hiroki Takahashi. Respir Res 2018
26
50

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
835
13

The Lung Microbiota of Healthy Mice Are Highly Variable, Cluster by Environment, and Reflect Variation in Baseline Lung Innate Immunity.
Robert P Dickson, John R Erb-Downward, Nicole R Falkowski, Ellen M Hunter, Shanna L Ashley, Gary B Huffnagle. Am J Respir Crit Care Med 2018
80
15

The lung tissue microbiome in chronic obstructive pulmonary disease.
Marc A Sze, Pedro A Dimitriu, Shizu Hayashi, W Mark Elliott, John E McDonough, John V Gosselink, Joel Cooper, Don D Sin, William W Mohn, James C Hogg. Am J Respir Crit Care Med 2012
308
12

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
912
11

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
11

Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation.
Leopoldo N Segal, Alexander V Alekseyenko, Jose C Clemente, Rohan Kulkarni, Benjamin Wu, Zhan Gao, Hao Chen, Kenneth I Berger, Roberta M Goldring, William N Rom,[...]. Microbiome 2013
208
11

Comparison of the respiratory microbiome in healthy nonsmokers and smokers.
Alison Morris, James M Beck, Patrick D Schloss, Thomas B Campbell, Kristina Crothers, Jeffrey L Curtis, Sonia C Flores, Andrew P Fontenot, Elodie Ghedin, Laurence Huang,[...]. Am J Respir Crit Care Med 2013
406
11

Dysregulated Lung Commensal Bacteria Drive Interleukin-17B Production to Promote Pulmonary Fibrosis through Their Outer Membrane Vesicles.
Daping Yang, Xi Chen, Jingjing Wang, Qi Lou, Yunwei Lou, Li Li, Honglin Wang, Jiangye Chen, Meng Wu, Xinyang Song,[...]. Immunity 2019
47
23

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
Anna L Peljto, Yingze Zhang, Tasha E Fingerlin, Shwu-Fan Ma, Joe G N Garcia, Thomas J Richards, Lori J Silveira, Kathleen O Lindell, Mark P Steele, James E Loyd,[...]. JAMA 2013
259
10

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
10

TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
Justin M Oldham, Shwu-Fan Ma, Fernando J Martinez, Kevin J Anstrom, Ganesh Raghu, David A Schwartz, Eleanor Valenzi, Leah Witt, Cathryn Lee, Rekha Vij,[...]. Am J Respir Crit Care Med 2015
151
10

The role of the microbiome in exacerbations of chronic lung diseases.
Robert P Dickson, Fernando J Martinez, Gary B Huffnagle. Lancet 2014
210
10

The role of infection in the pathogenesis of idiopathic pulmonary fibrosis.
Philip L Molyneaux, Toby M Maher. Eur Respir Rev 2013
93
10

Reagent and laboratory contamination can critically impact sequence-based microbiome analyses.
Susannah J Salter, Michael J Cox, Elena M Turek, Szymon T Calus, William O Cookson, Miriam F Moffatt, Paul Turner, Julian Parkhill, Nicholas J Loman, Alan W Walker. BMC Biol 2014
10

Topographical continuity of bacterial populations in the healthy human respiratory tract.
Emily S Charlson, Kyle Bittinger, Andrew R Haas, Ayannah S Fitzgerald, Ian Frank, Anjana Yadav, Frederic D Bushman, Ronald G Collman. Am J Respir Crit Care Med 2011
581
10


Spatial Variation in the Healthy Human Lung Microbiome and the Adapted Island Model of Lung Biogeography.
Robert P Dickson, John R Erb-Downward, Christine M Freeman, Lisa McCloskey, James M Beck, Gary B Huffnagle, Jeffrey L Curtis. Ann Am Thorac Soc 2015
192
9

Analysis of the lung microbiome in the "healthy" smoker and in COPD.
John R Erb-Downward, Deborah L Thompson, Meilan K Han, Christine M Freeman, Lisa McCloskey, Lindsay A Schmidt, Vincent B Young, Galen B Toews, Jeffrey L Curtis, Baskaran Sundaram,[...]. PLoS One 2011
530
9

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome.
J W Song, S-B Hong, C-M Lim, Y Koh, D S Kim. Eur Respir J 2011
411
9

The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial.
Matthew Hammond, Allan B Clark, Anthony P Cahn, Edwin R Chilvers, William Duncan Fraser, David M Livermore, Toby M Maher, Helen Parfrey, Ann Marie Swart, Susan Stirling,[...]. Trials 2018
15
60

The potential impact of azithromycin in idiopathic pulmonary fibrosis.
Claudio Macaluso, Joaquín Maritano Furcada, Omamah Alzaher, Ritesh Chaube, Felix Chua, Athol U Wells, Toby M Maher, Peter M George, Elizabeth A Renzoni, Philip L Molyneaux. Eur Respir J 2019
15
60

Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment.
Juliana Durack, Susan V Lynch, Snehal Nariya, Nirav R Bhakta, Avraham Beigelman, Mario Castro, Anne-Marie Dyer, Elliot Israel, Monica Kraft, Richard J Martin,[...]. J Allergy Clin Immunol 2017
108
9

Emerging pathogenic links between microbiota and the gut-lung axis.
Kurtis F Budden, Shaan L Gellatly, David L A Wood, Matthew A Cooper, Mark Morrison, Philip Hugenholtz, Philip M Hansbro. Nat Rev Microbiol 2017
389
9

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
8

Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.
Brett Ley, Jeffrey Swigris, Bann-Mo Day, John L Stauffer, Karina Raimundo, Willis Chou, Harold R Collard. Am J Respir Crit Care Med 2017
76
10

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
John Hutchinson, Andrew Fogarty, Richard Hubbard, Tricia McKeever. Eur Respir J 2015
314
8

Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial.
Ganesh Raghu, Carlos A Pellegrini, Eric Yow, Kevin R Flaherty, Keith Meyer, Imre Noth, Mary Beth Scholand, John Cello, Lawrence A Ho, Sudhakar Pipavath,[...]. Lancet Respir Med 2018
49
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.